August 2022 | VOL. 19, ED. 2
Colour PDF Greyscale PDF In this issue The waiting game: Australia’s capacity crunch for residential treatment Mick Palmer Q&A The World is Getting Creative for IOAD 2022! Co-occurring mental health and substance use crises: from ‘passing the buck’ to integrated care
July 2022 | VOL. 19, ED. 1
Colour PDF Greyscale PDF In this issue NSP Workers Report Growing Trend of Problematic Steroid Use Stories from the Frontline: Jo Beckett, Youth Projects The state of medicinal cannabis in Australia today Q&A Marguerite White
June 2022 | VOL. 18, ED. 10
Colour PDF Greyscale PDF In this issue Drugs and the 2022 Federal Election Hope on the Horizon: Trials target pharmacotherapy for methamphetamine use New Drug Price Regime Raises Questions Q&A Cheryl Delalande
May 2022 | VOL. 18, ED. 9
Colour PDF Greyscale PDF In this issue Standover tactics: how treatment can be hijacked by coercive control Standing firm: pharmacotherapy use stable as clients age Budget benefit: harm reduction affirmed in federal funding plan Q&A Donna Garcia
April 2022 | VOL. 18, ED. 8
Colour PDF Greyscale PDF In this issue Kick-start for ket: how ketamine emerged as Australia’s lockdown means of escape Highs and lows: how COVID has affected Australia’s use of drugs Soldiering on: in Ukraine, harm reductionists remain resolute against all odds Q&A with Fiona Patten: What we’re doing now doesn’t work
March 2022 | VOL. 18, ED. 7
Colour PDF Greyscale PDF In this issue Fentanyl fears: Australia alert to heightened overdose threat Naloxone’s Big 3: three lives a day saved by take-home supply Please explain: how NSP workers talk about their work and manage listeners’ reactions Q&A Senator Vernon White: ‘Almost any solution’s better than the status quo’
February 2022 | VOL. 18, ED. 6
Colour PDF Greyscale PDF In this issue Dial S for service: healthcare that’s only a call away Psyched in: psychedelics in the spotlight as trials begin Inside job: the not-so-social fallout of supplying friends Q&A Shane Neilson: ‘With international travel these days, the world is one market’
December 2021 | VOL. 18, ED. 5
Colour PDF Greyscale PDF In this issue ’Tis the season: Christmas brings excess in almost everything, alcohol and drugs included Minding our pees: what wastewater analysis can tell us about drugs Going… going… not gone: the unwelcome return of syphilis
November 2021 | VOL. 18, ED. 4
Colour PDF Greyscale PDF In this issue Pop-ups, podcasts and public libraries App attack: lockdown spurs move to social media marketplace Lethal cocktails: poly-drug mixes the common denominator in overdose ‘That could be your brother or your sister or yourself’: Q&A with Allan Ragi
October 2021 | VOL. 18, ED. 3
Colour PDF Greyscale PDF In this issue Into the deep: the clandestine world of the dark web marketplace Violent overlap: In the drug world, the hits keep coming More art than science: NSP community consultation is a must Setting the pace: ‘We were the first NSP to be state-funded anywhere in the world’